Day: November 18, 2021

Mettler-Toledo International Inc. Announces Webcast of Presentation at the virtual Evercore ISI 4th Annual HealthCONx Conference

Written by Customer Service on November 18, 2021. Posted in Public Companies.

Columbus, OH, Nov. 18, 2021 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the virtual Evercore ISI 4th Annual HealthCONx Conference on Thursday, December 2, 2021, at 11:20 a.m. Eastern Time. To hear a live webcast of the presentation, visit the investor relations page on the Company’s Web site at www.mt.com/investors. A replay of the webcast will be available for seven days. METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide...

EnergySolutions Announces that TriArtisan Capital Advisors to Acquire Majority Ownership of the Company

Written by Customer Service on November 18, 2021. Posted in Mergers And Acquisitions.

SALT LAKE CITY, Nov. 18, 2021 (GLOBE NEWSWIRE) — EnergySolutions (the “Company”), today announced that current shareholder TriArtisan Capital Advisors LLC (“TriArtisan”) has signed a definitive agreement to acquire the remaining ownership interest in the Company from its current majority owner ECP. Terms of the transaction were not disclosed. EnergySolutions, headquartered in Salt Lake City, Utah, is a leading international nuclear services company that provides integrated services and solutions to the nuclear industry, and owns state-of-the-art facilities to safely recycle, process and dispose of nuclear material. EnergySolutions CEO Ken Robuck, said “We are delighted that TriArtisan has made a substantial additional investment in the Company to become our majority owner, and we look forward to continuing our close partnership...

Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart

Written by Customer Service on November 18, 2021. Posted in Public Companies.

A new Stanford study published in Cell Host and Microbe finds that protection against influenza infection may be achieved through mechanisms other than the development of serum antibodies STANFORD, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — A new Stanford study published in Cell Host and Microbe has demonstrated that VXA-A1.1, an investigational oral tablet flu vaccine under development by Vaxart, Inc. (NASDAQ: VXRT), had cellular correlates of protection against influenza infection.1 These cellular correlates were found using mass cytometry analysis of vaccine-elicited cellular immune responses in the peripheral blood of participants in a previously reported Phase II H1N1 challenge study of VXA-A1.1.2 The U.S. Centers for Disease Control and Prevention (CDC) estimates that, on average, 36,000 people in the U.S. died from the flu...

Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis

Written by Customer Service on November 18, 2021. Posted in Public Companies.

Primary endpoint met with all three CBP-201 arms achieving significant improvements Significant improvements also reported for key secondary endpoints including other measures of skin clearance and itch with CBP-201 300mg every two weeks (Q2W) arm The Company intends to initiate a Phase 3 trial program in mid-2022 SAN DIEGO and TAICANG, SUZHOU, China , Nov. 18, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research, today reported positive topline results from the global Phase 2 clinical trial of CBP-201 administered subcutaneously (SC) to adult patients with...

ProQR Announces Highlights from Analyst Event

Written by Customer Service on November 18, 2021. Posted in Public Companies.

LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today hosted a virtual Analyst Event. Management provided an in-depth review of the Company’s clinical-stage programs and RNA editing technology platforms. A webcast replay of the event including slides is available from the “Investors & Media” section of ProQR’s website (www.proqr.com) under “Events”. Highlights from today’s presentations include the following: Sepofarsen for CEP290-mediated Leber congenital amaurosis 10 (LCA10):The Company expects to report top-line results from the Phase 2/3 Illuminate trial in late Q1/early Q2 2022. The Illuminate trial completed enrollment...

Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

Written by Customer Service on November 18, 2021. Posted in Public Companies.

WALTHAM, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS), a global biopharmaceutical company and leader in complement, today announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,312,500 shares at the public offering price of $40.00 per share. The exercise of the option to purchase additional shares brought the total number of shares of common stock sold by Apellis to 10,062,500 shares and increased the amount of gross proceeds, before deducting underwriting discounts and commissions and expenses payable by Apellis, to $402.5 million. J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C. acted as joint book-running managers for...

Workday Announces Intent to Acquire VNDLY

Written by Customer Service on November 18, 2021. Posted in Mergers And Acquisitions.

Combination Will Provide Customers with a Unified Workforce Optimization Solution for Managing All Types of Workers PLEASANTON, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ:WDAY), a leader in enterprise cloud applications for finance and human resources, has entered into a definitive agreement to acquire VNDLY, an industry leader in cloud-based external workforce and vendor management technology. With VNDLY, Workday will provide organizations with a unified workforce optimization solution that will help organizations manage all types of workers—salaried, hourly, contingent, and outsourced—and support a holistic talent strategy, including insight into costs, workforce planning needs, and compliance. A Unified Solution to Support Evolving Workforce Dynamics The future of work requires new ways of thinking about...

NuCana Reports Third Quarter 2021 Financial Results and Provides Business Update

Written by Customer Service on November 18, 2021. Posted in Earnings Releases And Operating Results.

Enrolled Required Number of Patients to Conduct First Interim Analysis in Phase 3 Biliary Tract Cancer Study in the First Half of 2022 Received Fast Track Designation from FDA for Acelarin for the Treatment of Patients with Biliary Tract Cancer Announced Additional Encouraging Clinical Data for NUC-3373 and NUC-7738 at ESMO Multiple Near-Term Study Initiations and Data Announcements Expected EDINBURGH, United Kingdom, Nov. 18, 2021 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the third quarter ended September 30, 2021 and provided an update on its broad clinical program with its transformative ProTide therapeutics. As of September 30, 2021, NuCana had cash and cash equivalents of £71.0 million compared to £73.4 million at June 30, 2021 and £87.4 million as of December 31, 2020. NuCana continues to...

Workday Announces Fiscal 2022 Third Quarter Financial Results

Written by Customer Service on November 18, 2021. Posted in Earnings Releases And Operating Results.

Fiscal Third Quarter Total Revenues of $1.33 Billion, Up 20.0% Year Over YearSubscription Revenue of $1.17 Billion, Up 21.0% Year Over Year24-Month Subscription Revenue Backlog of $7.12 Billion, Up 19.7% Year Over YearTotal Subscription Revenue Backlog of $10.97 Billion, Up 23.7% Year Over Year PLEASANTON, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — Workday, Inc. (NASDAQ: WDAY), a leader in enterprise cloud applications for finance and human resources, today announced results for the fiscal 2022 third quarter ended October 31, 2021. Fiscal 2022 Third Quarter ResultsTotal revenues were $1.33 billion, an increase of 20.0% from the third quarter of fiscal 2021. Subscription revenue was $1.17 billion, an increase of 21.0% from the same period last year. Operating income was $23.9 million, or 1.8% of revenues, compared to an operating...

Applied Materials Announces Fourth Quarter and Fiscal Year 2021 Results

Written by Customer Service on November 18, 2021. Posted in Earnings Releases And Operating Results.

Record annual revenue of $23.06 billion, up 34 percent year over year Record annual GAAP operating margin of 29.9 percent, non-GAAP operating margin of 31.7 percent, GAAP EPS of $6.40 and non-GAAP EPS of $6.84 Quarterly revenue of $6.12 billion, up 31 percent year over year Record quarterly GAAP operating margin of 32.9 percent, non-GAAP operating margin of 33.1 percent, GAAP EPS of $1.89 and non-GAAP EPS of $1.94SANTA CLARA, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its fourth quarter and fiscal year ended Oct. 31, 2021. Fourth Quarter Results Applied generated revenue of $6.12 billion, which was at the low end of the guidance range due to supply chain challenges. On a GAAP basis, the company recorded gross margin of 48.1 percent, operating income of $2.01 billion...

Day: November 18, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice